Prevalence, Management, and Outcomes of SARS-CoV-2 Infections in Older People and Those with Dementia in Mental Health Wards in London, UK: a Retrospective Observational Study
Overview
Authors
Affiliations
Background: People living in group situations or with dementia are more vulnerable to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Older people and those with multimorbidity have higher mortality if they become infected than the general population. However, no systematic study exists of COVID-19-related outcomes in older inpatients in psychiatric units, who comprise people from these high-risk groups. We aimed to describe the period prevalence, demographics, symptoms (and asymptomatic cases), management, and survival outcomes of COVID-19 in the older inpatient psychiatric population and people with young-onset dementia in five National Health Service Trusts in London, UK, from March 1 to April 30, 2020.
Methods: In this retrospective observational study, we collected demographic data, mental health diagnoses, clinical diagnosis of COVID-19, symptoms, management, and COVID-19-related outcome data of inpatients aged 65 years or older or with dementia who were already inpatients or admitted as inpatients to five London mental health Trusts between March 1 and April 30, 2020, and information about available COVID-19-related resources (ie, testing and personal protective equipment). Patients were determined to have COVID-19 if they had a positive SARS-CoV-2 PCR test, or had relevant symptoms indicative of COVID-19, as determined by their treating physician. We calculated period prevalence of COVID-19 and analysed patients' characteristics, treatments, and outcomes.
Findings: Of 344 inpatients, 131 (38%) were diagnosed with COVID-19 during the study period (period prevalence 38% [95% CI 33-43]). The mean age of patients who had COVID-19 was 75·3 years (SD 8·2); 68 (52%) were women and 47 (36%) from ethnic minority groups. 16 (12%) of 131 patients were asymptomatic and 121 (92%) had one or more disease-related comorbidity. 108 (82%) patients were compulsorily detained. 74 (56%) patients had dementia, of whom 13 (18%) had young-onset dementia. On average, sites received COVID-19 testing kits 4·5 days after the first clinical COVID-19 presentation. 19 (15%) patients diagnosed with COVID-19 died during the study period, and their deaths were determined to be COVID-19 related.
Interpretation: Patients in psychiatric inpatient settings who were admitted without known SARS-CoV-2 infection had a high risk of infection with SARS-CoV-2 compared with those in the community and had a higher proportion of deaths from COVID-19 than in the community. Implementation of the long-standing policy of parity of esteem for mental health and planning for future COVID-19 waves in psychiatric hospitals is urgent.
Funding: None.
Das-Munshi J, Bakolis I, Becares L, Dasch H, Dyer J, Hotopf M Psychol Med. 2024; :1-11.
PMID: 39428656 PMC: 11536139. DOI: 10.1017/S0033291724001843.
Bicalho M, Aliberti M, Delfino-Pereira P, Chagas V, Rosa P, Pires M BMC Geriatr. 2024; 24(1):25.
PMID: 38182982 PMC: 10770897. DOI: 10.1186/s12877-023-04494-w.
Mazzalai E, Giannini D, Tosti M, DAngelo F, Declich S, Jaljaa A J Int Migr Integr. 2023; :1-31.
PMID: 36647529 PMC: 9833641. DOI: 10.1007/s12134-023-01007-x.
Paruk S, Ngcobo N, Karim E, Tomita A, Ramlall S S Afr J Psychiatr. 2022; 28:1933.
PMID: 36569809 PMC: 9772653. DOI: 10.4102/sajpsychiatry.v28i0.1933.
Vardavas C, Mathioudakis A, Nikitara K, Stamatelopoulos K, Georgiopoulos G, Phalkey R Eur Respir Rev. 2022; 31(166).
PMID: 36323422 PMC: 9724816. DOI: 10.1183/16000617.0098-2022.